Literature DB >> 1483790

Haemostasis at high altitude.

G Le Roux1, P Larmignat, M Marchal, J P Richalet.   

Abstract

Haemostasis has been studied by several authors during exposure to altitude hypoxia. On acute induction to hypoxia, platelet count, platelet aggregability and bleeding time are normal; an increase of thromboxane released from platelets and of prostacyclin, released from endothelial cells is observed; coagulation factors are unchanged except of F. VIII which is increased; modified antithrombin III (ATm) are normal; fibrinopeptide A is increased in subjects with pulmonary edema and fibrinolytic activity after venous occlusion is normal. In chronic hypoxia, during a stay at 6542 m (Mt. Sajama), we found in 7 subjects an important increase in D. Dimer (p < 0.001) that seems to correspond to an activation of coagulation and a decrease of F. VIII R. Cof/F. VIII R. Ag ratio which suggests an endothelial cell damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483790     DOI: 10.1055/s-2007-1024592

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  9 in total

1.  D-dimer in the diagnostic workup of suspected pulmonary thrombo-embolism at high altitude.

Authors:  Kr Rathi; Vikram Uppal; Nm Bewal; Debraj Sen; Anurag Khanna
Journal:  Med J Armed Forces India       Date:  2012-04-21

2.  PAIN ABDOMEN AT EXTREME ALTITUDES: SINISTER IMPLICATIONS.

Authors:  A C Anand; A Saha; V Sharma; H S Nanda; C M Adya; V Singh
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients.

Authors:  Riccardo Polosa; Mario Malerba; Rossella R Cacciola; Jaymin B Morjaria; Cinzia Maugeri; Gaetano Prosperini; Raimondo Gullo; Lucia Spicuzza; Alessandro Radaeli; Giuseppe U Di Maria
Journal:  Intern Emerg Med       Date:  2011-06-10       Impact factor: 3.397

4.  Does altitude or exercise induce fibrin degradation in mountaineers?

Authors:  G Roeggla; M Roeggla; M Binder; A Wagner
Journal:  J R Soc Med       Date:  1995-04       Impact factor: 5.344

5.  Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study.

Authors:  Lewis Fall; Julien V Brugniaux; Danielle Davis; Christopher J Marley; Bruce Davies; Karl J New; Jane McEneny; Ian S Young; Damian M Bailey
Journal:  J Physiol       Date:  2018-08-29       Impact factor: 5.182

6.  Modulation of lung cytoskeletal remodeling, RXR based metabolic cascades and inflammation to achieve redox homeostasis during extended exposures to lowered pO2.

Authors:  Subhojit Paul; Anamika Gangwar; Aditya Arya; Kalpana Bhargava; Yasmin Ahmad
Journal:  Apoptosis       Date:  2021-05-17       Impact factor: 4.677

Review 7.  Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine.

Authors:  Gianfranco Parati; Piergiuseppe Agostoni; Buddha Basnyat; Grzegorz Bilo; Hermann Brugger; Antonio Coca; Luigi Festi; Guido Giardini; Alessandra Lironcurti; Andrew M Luks; Marco Maggiorini; Pietro A Modesti; Erik R Swenson; Bryan Williams; Peter Bärtsch; Camilla Torlasco
Journal:  Eur Heart J       Date:  2018-05-01       Impact factor: 29.983

8.  Preoperative Aspirin Management in Redo Tetralogy of Fallot Population: Single Centre Experience.

Authors:  Giuseppe Comentale; Gaetano Palma; Valentina Parisi; Silvio Simeone; Gianluca Pucciarelli; Rachele Manzo; Emanuele Pilato; Raffaele Giordano
Journal:  Healthcare (Basel)       Date:  2020-11-03

Review 9.  Recommendations for traveling to altitude with neurological disorders.

Authors:  Marika Falla; Guido Giardini; Corrado Angelini
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.